Cargando…
Potential Targeting of Siglecs, Mast Cell Inhibitory Receptors, in Interstitial Cystitis
Mast cell increases and activation are detected in the chronic inflammatory bladder disease interstitial cystitis (IC), and their proinflammatory mediators are felt to contribute to regional pelvic pain and inflammatory pathophysiology. The immunoreceptor tyrosine-based inhibition motif-containing s...
Autores principales: | Park, Chang-Shin, Bochner, Bruce S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Continence Society
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138845/ https://www.ncbi.nlm.nih.gov/pubmed/21811694 http://dx.doi.org/10.5213/inj.2011.15.2.61 |
Ejemplares similares
-
New Insights into the Mechanism of the Down-Regulation of Mast Cells in the Treatment of Interstitial Cystitis: Possible Role of Siglecs
por: Lee, Tack
Publicado: (2011) -
Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells
por: Robida, Piper A., et al.
Publicado: (2022) -
Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice
por: Wei, Yadong, et al.
Publicado: (2018) -
Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cells
por: Cao, Yun, et al.
Publicado: (2023) -
The importance of mast cells in interstitial cystitis/bladder pain syndrome
por: Ratner, Vicki
Publicado: (2016)